416 related articles for article (PubMed ID: 34105826)
1. Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression.
Liu L; Yu H; Long Y; You Z; Ogawa R; Du Y; Huang C
FASEB J; 2021 Jul; 35(7):e21705. PubMed ID: 34105826
[TBL] [Abstract][Full Text] [Related]
2. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids.
Lee WJ; Ahn HM; Roh H; Na Y; Choi IK; Lee JH; Kim YO; Lew DH; Yun CO
Exp Dermatol; 2015 Aug; 24(8):591-7. PubMed ID: 25865370
[TBL] [Abstract][Full Text] [Related]
3. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
Marty P; Chatelain B; Lihoreau T; Tissot M; Dirand Z; Humbert P; Senez C; Secomandi E; Isidoro C; Rolin G
Biomed Pharmacother; 2021 Mar; 135():111182. PubMed ID: 33433355
[TBL] [Abstract][Full Text] [Related]
4. Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.
Lv W; Wu M; Ren Y; Luo X; Hu W; Zhang Q; Wu Y
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200804
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
6. Keloid disorder: Fibroblast differentiation and gene expression profile in fibrotic skin diseases.
Macarak EJ; Wermuth PJ; Rosenbloom J; Uitto J
Exp Dermatol; 2021 Jan; 30(1):132-145. PubMed ID: 33211348
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts.
Hasegawa T; Nakao A; Sumiyoshi K; Tsuboi R; Ogawa H
J Dermatol Sci; 2003 Jun; 32(1):19-24. PubMed ID: 12788525
[TBL] [Abstract][Full Text] [Related]
8. The "Matrisome" reveals the characterization of skin keloid microenvironment.
Zhang S; Liu B; Wang W; Lv L; Gao D; Chai M; Li M; Wu Z; Zhu Y; Ma J; Leng L
FASEB J; 2021 Apr; 35(4):e21237. PubMed ID: 33715180
[TBL] [Abstract][Full Text] [Related]
9. Decoy Wnt receptor (sLRP6E1E2)-expressing adenovirus induces anti-fibrotic effect via inhibition of Wnt and TGF-β signaling.
Lee WJ; Lee JS; Ahn HM; Na Y; Yang CE; Lee JH; Hong J; Yun CO
Sci Rep; 2017 Nov; 7(1):15070. PubMed ID: 29118355
[TBL] [Abstract][Full Text] [Related]
10. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
Imaizumi R; Akasaka Y; Inomata N; Okada E; Ito K; Ishikawa Y; Maruyama Y
Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids.
Inui S; Shono F; Nakajima T; Hosokawa K; Itami S
Am J Pathol; 2011 Oct; 179(4):1951-60. PubMed ID: 21872564
[TBL] [Abstract][Full Text] [Related]
12. Collagen triple helix repeat containing-1 inhibits transforming growth factor-b1-induced collagen type I expression in keloid.
Li J; Cao J; Li M; Yu Y; Yang Y; Xiao X; Wu Z; Wang L; Tu Y; Chen H
Br J Dermatol; 2011 May; 164(5):1030-6. PubMed ID: 21667528
[TBL] [Abstract][Full Text] [Related]
13. Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression.
Li J; Li Z; Wang S; Bi J; Huo R
Bioengineered; 2022 Apr; 13(4):8515-8525. PubMed ID: 35333672
[TBL] [Abstract][Full Text] [Related]
14. TWEAK/Fn14 signaling may function as a reactive compensatory mechanism against extracellular matrix accumulation in keloid fibroblasts.
Zhang Y; Li X; Liu W; Hu G; Gu H; Cui X; Zhang D; Zeng W; Xia Y
Eur J Cell Biol; 2023 Jun; 102(2):151290. PubMed ID: 36709605
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases.
Deng CC; Hu YF; Zhu DH; Cheng Q; Gu JJ; Feng QL; Zhang LX; Xu YP; Wang D; Rong Z; Yang B
Nat Commun; 2021 Jun; 12(1):3709. PubMed ID: 34140509
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of genistein ability to modulate CTGF mRNA/protein expression, genes expression of TGFβ isoforms and expression of selected genes regulating cell cycle in keloid fibroblasts in vitro.
Jurzak M; Adamczyk K; Antończak P; Garncarczyk A; Kuśmierz D; Latocha M
Acta Pol Pharm; 2014; 71(6):972-86. PubMed ID: 25745770
[TBL] [Abstract][Full Text] [Related]
17. Ameliorating Fibrotic Phenotypes of Keloid Dermal Fibroblasts through an Epidermal Growth Factor-Mediated Extracellular Matrix Remodeling.
Kim H; Anggradita LD; Lee SJ; Hur SS; Bae J; Hwang NS; Nam SM; Hwang Y
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672186
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.
Daian T; Ohtsuru A; Rogounovitch T; Ishihara H; Hirano A; Akiyama-Uchida Y; Saenko V; Fujii T; Yamashita S
J Invest Dermatol; 2003 Jun; 120(6):956-62. PubMed ID: 12787120
[TBL] [Abstract][Full Text] [Related]
19. Keloids show regional distribution of proliferative and degenerate connective tissue elements.
Bux S; Madaree A
Cells Tissues Organs; 2010; 191(3):213-34. PubMed ID: 19641294
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]